Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Prostate Cancer |
Free Subscription
3 BJU Int |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Prostate tumour visualisation with PET: is image fusion with MRI the answer?
BJU Int. 2024;133 Suppl 4:4-6.
PubMed
Population-based study of disease trajectory after radical treatment for
high-risk prostate cancer.
BJU Int. 2024 Apr 15. doi: 10.1111/bju.16362.
PubMed
Abstract available
The FocAL therapy CONsensus (FALCON): enhancing partial gland ablation for
localised prostate cancer.
BJU Int. 2024 Apr 13. doi: 10.1111/bju.16360.
PubMed
Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific
membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in
CTCs and plasma exosome-derived cfRNA in patients with metastatic
castration-resistant prostate c
BMC Cancer. 2024;24:482.
PubMed
Abstract available
Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut
microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.
BMC Cancer. 2024;24:472.
PubMed
Abstract available
A novel biopsy scheme for prostate cancer: targeted and regional systematic
biopsy.
BMC Urol. 2024;24:85.
PubMed
Abstract available
PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP
Exacerbate Racial Disparities in Prostate Cancer.
Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-3458.
PubMed
Abstract available
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating
PSMA-Positive Tumors.
Clin Cancer Res. 2024;30:1595-1606.
PubMed
Abstract available
MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and
diagnostic performance of the PI-FAB score.
Eur J Radiol. 2024;175:111463.
PubMed
Abstract available
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I:
Screening, Diagnosis, and Local Treatment with Curative Intent.
Eur Urol. 2024 Apr 12:S0302-2838(24)02254-1. doi: 10.1016/j.eururo.2024.
PubMed
Abstract available
Re: Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer.
Eur Urol. 2024 Apr 11:S0302-2838(24)02258-9. doi: 10.1016/j.eururo.2024.
PubMed
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic
Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and
International Consensus Recommendations.
Eur Urol. 2024;85:466-482.
PubMed
Abstract available
Re: Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, et al.
Prostate-specific Membrane Antigen Reporting and Data System Version 2.0. Eur
Urol 2023;84:491-502.
Eur Urol. 2024;85:e145.
PubMed
Reply to Madhur Anand, Bela Jain, and Swati Aggarwal's Letter to the Editor re:
Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, et al.
Prostate-Specific Membrane Antigen Reporting and Data System Version 2.0. Eur
Urol 2023;84:491-502.
Eur Urol. 2024;85:e146-e147.
PubMed
Long term evaluation of optimized Gleason grading in a large cohort of men with
prostate cancer in Canada.
Hum Pathol. 2024 Apr 10:S0046-8177(24)00054.
PubMed
Abstract available
Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A
Secondary Analysis of a Phase 3 Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys. 2024;119:119-126.
PubMed
Abstract available
KDM3B Single-Nucleotide Polymorphisms Impact Radiation Therapy Toxicity Through
Circular RNA-Mediated KDM3B Expression and Inflammatory Responses.
Int J Radiat Oncol Biol Phys. 2024;119:251-260.
PubMed
Abstract available
Late Toxicity of Prostate Ultrahypofractionated Radiation Therapy Compared With
Moderate Hypofractionation in a Randomized Trial.
Int J Radiat Oncol Biol Phys. 2024;119:110-118.
PubMed
Abstract available
Validation of schedules for optimal prostate-specific antigen monitoring after
radical prostatectomy.
Int J Urol. 2024;31:404-408.
PubMed
Abstract available
Erratum: Alcohol Intake and Risk of Lethal Prostate Cancer in the Health
Professionals Follow-Up Study.
J Clin Oncol. 2024 Apr 16:JCO2400454. doi: 10.1200/JCO.24.00454.
PubMed
RECIP 1.0 Predicts Progression-Free Survival After [(177)Lu]Lu-PSMA
Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant
Prostate Cancer.
J Nucl Med. 2024 Apr 18:jnumed.123.267234. doi: 10.2967/jnumed.123.267234.
PubMed
Abstract available
[(177)Lu]Lu-Prostate-Specific Membrane Antigen-617 in a Patient with Metastatic
Castration-Resistant Prostate Cancer and Status After Bilateral Nephrectomy.
J Nucl Med. 2024 Apr 18:jnumed.124.267533. doi: 10.2967/jnumed.124.267533.
PubMed
Combining enzalutamide and [(177)Lu]Lu-PSMA-617 in metastatic
castration-resistant prostate cancer.
Lancet Oncol. 2024 Apr 12:S1470-2045(24)00179.
PubMed
[(177)Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic
castration-resistant prostate cancer (ENZA-p): an open-label, multicentre,
randomised, phase 2 trial.
Lancet Oncol. 2024 Apr 12:S1470-2045(24)00135.
PubMed
Abstract available
Unlocking ferroptosis in prostate cancer - the road to novel therapies and
imaging markers.
Nat Rev Urol. 2024 Apr 16. doi: 10.1038/s41585-024-00869.
PubMed
Abstract available
Correction: In vivo genome-wide CRISPR screening identifies CITED2 as a driver of
prostate cancer bone metastasis.
Oncogene. 2024 Apr 16. doi: 10.1038/s41388-024-03031.
PubMed
Abscisic acid signaling through LANCL2 and PPARgamma induces activation of p38MAPK
resulting in dormancy of prostate cancer metastatic cells.
Oncol Rep. 2024;51:39.
PubMed
Abstract available
[Corrigendum] Cripto?1 promotes epithelial?mesenchymal transition in prostate
cancer via Wnt/beta?catenin signaling.
Oncol Rep. 2024;51:75.
PubMed
Abstract available
Bayesian approach to assessing population differences in genetic risk of disease
with application to prostate cancer.
PLoS Genet. 2024;20:e1011212.
PubMed
Abstract available
Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with
Lynch syndrome.
Prostate. 2024 Apr 17. doi: 10.1002/pros.24711.
PubMed
Abstract available
Multispecies comparative prostate anatomy by imaging: Implications for
experimental models of prostatic disease.
Prostate. 2024;84:682-693.
PubMed
Abstract available
Preanalytical stability of molecular forms of prostate-specific antigen in serum
samples (PSA, free PSA, [-2]proPSA) and their impact on fPSA/tPSA ratio and PHI.
Prostate. 2024;84:656-665.
PubMed
Abstract available
Cancer cells employ lipid droplets to survive toxic stress.
Prostate. 2024;84:644-655.
PubMed
Abstract available
Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker
of proliferation Ki67.
Prostate. 2024 Apr 17. doi: 10.1002/pros.24710.
PubMed
Abstract available
FOXA1 regulates ribosomal RNA transcription in prostate cancer.
Prostate. 2024 Apr 17. doi: 10.1002/pros.24714.
PubMed
Abstract available
Novel Prostate Biopsy Technique Using Imaging Fusion in a Patient With Absent
Rectum.
Urology. 2024;185:124-130.
PubMed
Abstract available
Urinary Symptoms Change and Quality of Life After Robotic Radical Prostatectomy:
A Secondary Analysis of a Randomized Controlled Trial.
Urology. 2024;185:73-79.
PubMed
Abstract available
Thank you for your interest in scientific medicine.